Early research (Phase 1)Active Not RecruitingNCT06556147What this trial is testingRSV-HMPV Bivalent Vaccine VXB-241 in Older AdultsWho this might be right forHealthy Volunteers Sanofi 144
Testing effectiveness (Phase 2)Study completedNCT05921903What this trial is testingA Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 386
Large-scale testing (Phase 3)Study completedNCT05559476What this trial is testingA Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 1,029
Early research (Phase 1)Study completedNCT02201303What this trial is testingEvaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface ExpressionWho this might be right forInfections, Respiratory Syncytial Virus GlaxoSmithKline 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07041190What this trial is testingPregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.Who this might be right forRSV Immunization PENTA Foundation 1,500
Very early researchStudy completedNCT05148780What this trial is testingAcute Respiratory Infections in Global Outpatient SettingWho this might be right forAcute Respiratory Infection Janssen Research & Development, LLC 245
Early research (Phase 1)Study completedNCT06917508What this trial is testingEvaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy ParticipantsWho this might be right forRSV InfectionDrug Drug Interaction Enanta Pharmaceuticals, Inc 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT07717840What this trial is testingCharacterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)Who this might be right forRSV Respiratory Syncytial Virus AstraZeneca 164
Large-scale testing (Phase 3)Ended earlyNCT04583280What this trial is testingRilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)Who this might be right forRespiratory Tract Infections Janssen Research & Development, LLC 28
Early research (Phase 1)Study completedNCT02298179What this trial is testingEvaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy AdultsWho this might be right forRespiratory Syncytial Virus (RSV) GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT02442427What this trial is testing"Palivizumab Therapy for RSV-bronchiolitis"Who this might be right forRespiratory Syncytial Virus-bronchiolitis Hamad Medical Corporation 420
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654What this trial is testingStudy of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and OlderWho this might be right forHuman Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization Sanofi Pasteur, a Sanofi Company 1,530
Testing effectiveness (Phase 2)Looking for participantsNCT06684379What this trial is testingStudy on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)Who this might be right forSARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more PEACHES BIOTECH 50
Not applicableStudy completedNCT01090557What this trial is testingExhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot StudyWho this might be right forRSV InfectionBronchiolitis Winthrop University Hospital 60
Early research (Phase 1)Study completedNCT06601192What this trial is testingInvestigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy AdultsWho this might be right forRSV InfectionQTc Interval Enanta Pharmaceuticals, Inc 72
Testing effectiveness (Phase 2)Study completedNCT06097299What this trial is testingMRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial VirusWho this might be right forRespiratory Syncytial Virus ModernaTX, Inc. 349
Not applicableStudy completedNCT02853838What this trial is testingChest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)Who this might be right forBronchiolitis, Viral Universidad del Desarrollo 204
Early research (Phase 1)WithdrawnNCT02864628What this trial is testingRSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.Who this might be right forRespiratory Syncytial Virus Infections Bavarian Nordic
Large-scale testing (Phase 3)Study completedNCT02624947What this trial is testingDetermine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal ImmunizationWho this might be right forRespiratory Syncytial Virus Infections Novavax 4,636
Early research (Phase 1)Study completedNCT03387137What this trial is testingEvaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and ChildrenWho this might be right forRSV Infection National Institute of Allergy and Infectious Diseases (NIAID) 45